Ϫ/Ϫ mice) were generated using loxP/Cre technology. ePPAR␦ Ϫ/Ϫ mice were normotensive and did not display any sign of metabolic syndrome. Endothelium-dependent relaxations to ACh and endotheliumindependent relaxations to the nitric oxide (NO) donor diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate were both significantly impaired in the aorta and carotid arteries of ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05). In ePPAR␦ Ϫ/Ϫ mouse aortas, phosphorylation of endothelial NO synthase at Ser 1177 was significantly decreased (P Ͻ 0.05). However, basal levels of cGMP were unexpectedly increased (P Ͻ 0.05). Enzymatic activity of GTP-cyclohydrolase I and tetrahydrobiopterin levels were also enhanced in ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05). Most notably, endothelium-specific deletion of the PPAR-␦ gene significantly decreased protein expressions of catalase and glutathione peroxidase 1 and resulted in increased levels of H 2O2 in the aorta (P Ͻ 0.05). In contrast, superoxide anion production was unaltered. Moreover, treatment with catalase prevented the endothelial dysfunction and elevation of cGMP detected in aortas of ePPAR␦ Ϫ/Ϫ mice. The findings suggest that increased levels of cGMP caused by H 2O2 impair vasodilator reactivity to endogenous and exogenous NO. We speculate that chronic elevation of H 2O2 predisposes PPAR-␦-deficient arteries to oxidative stress and vascular dysfunction. endothelial dysfunction; nitric oxide; tetrahydrobiopterin; carotid artery; hydrogen peroxide; peroxisome proliferator-activated receptor-␦; endothelial nitric oxide synthase PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-␦, together with PPAR-␣ and PPAR-␥, constitute the PPAR subfamily of the nuclear receptor superfamily (6) . All three PPAR subtypes share structural and functional similarities and control transcription through binding to specific PPAR-responsive elements in the target gene promoters and also repress gene transcription by a mechanism that is independent of DNA binding (19) . PPAR-␦ is ubiquitously expressed in tissues (35) , and activation of PPAR-␦ exerts many favorable metabolic effects, including reduced weight gain, increased skeletal muscle metabolic rate, and improved insulin sensitivity (30, 38, 44, 51) . In addition, it has been previously demonstrated that treatment with a PPAR-␦ agonist suppresses vascular inflammation and prevents atherosclerosis in apolipoprotein E-deficient mice (5, 29) , indicating that stimulation of PPAR-␦ is vasoprotective (49) .
The vascular endothelium plays an essential role in the regulation of vascular tone (31) . Endothelial dysfunction characterized by reduced bioavailability of nitric oxide (NO) is an early event in the pathogenesis of atherosclerosis (40) . NO is mainly formed in endothelial cells from L-arginine by the enzymatic activity of endothelial NO synthase (eNOS) (34) . Activation of smooth muscle guanylate cyclase by NO causes increased formation of cGMP and vasodilation (37) . Relevant to our study, PPAR-␦ is expressed in endothelial cells (17, 36) , and activation of PPAR-␦ results in increased NO bioavailability and preserved endothelial function (14, 47, 55) . Moreover, both in vitro and in vivo studies (2, 14, 17, 41, 50) have indicated that increased antioxidant capacity is one of the important molecular mechanisms involved in the protective effects of PPAR-␦ activation.
While endothelium-specific deletion of PPAR-␥ impairs endothelium-dependent relaxations to ACh in mice aortas (27) , the effects of PPAR-␦ deficiency on endothelial function are unknown. PPAR-␦ knockout mice have been developed; however, global deletion of PPAR-␦ leads to embryonic lethality and growth retardation in surviving mice (4, 35) . Tissuerestricted gene-targeting technology provides an alternative approach to address the tissue-specific role of PPAR-␦ (9). To date, there have been no reported studies regarding the vascular phenotype of endothelium-specific PPAR-␦-deficient mice (ePPAR␦ Ϫ/Ϫ mice). Therefore, the objective of the present study was to characterize vascular endothelial function in conduit arteries of ePPAR␦ Ϫ/Ϫ mice. were kindly provided by R. M. Evans (The Salk Institute, La Jolla, CA). Originally, mice harboring loxP sites on either side of exon 4 of the PPAR-␦ gene were generated and backcrossed to C57BL/6 mice as previously described (4) . Floxed PPAR-␦ mice were crossed with transgenic mice expressing Cre recombinase (Tie2-Cre, stock no. 004128, Jackson Laboratory, Bar Harbor, ME). Selected descendants were bred to generate both floxed ePPAR␦ Ϫ/Ϫ mice and their littermate controls.
MATERIALS AND METHODS

Generation of ePPAR␦
Male ePPAR␦ Ϫ/Ϫ (PPAR␦ flox/flox ; Cre ϩ ) mice were crossed with female control (PPAR␦ flox/flox ; Cre Ϫ ) mice to generate offspring in our laboratory. At 4 -5 wk of age, mice were anesthetized with 1% isoflurane, and tail snips were analyzed by PCR. Genotyping was performed using Cre primers according to the protocol from the Jackson Laboratory (stock no. 004128). To confirm endotheliumspecific deletion of PPAR-␦, dissected aortas were rinsed in Krebs solution, and endothelial cells were flushed out of the aorta with lysis buffer (PureLink RNA Mini Kit, Ambion, Carlsbad, CA). The isolation and purification of total mRNA were performed according to the manufacturer's instructions (PureLink RNA Mini Kit, Ambion). Thereafter, cDNA was synthetized using SuperScript III (Invitrogen, Carlsbad, CA) and was subjected to PCR analysis using primers spanning the deletion site (exon 4) in the PPAR-␦ gene (GenBank Accession No. NM_011145, forward: 5=-TTCCTCCCCTTCCTC-CCTGC-3= and reverse: 5=-GTGGACCCCGTAGTGGAAGC-3=). As a reference control, GAPDH (GenBank Accession No. NM_008084, forward: 5=-TGCCAAGGCTGTGGGCAAGG-3= and reverse: 5=-TGGGCCCTCAGATGCCTGCT-3=) was used. The following conditions were used for PCR: 95°C for 30 s, 58°C for 30 s, and 72°C for 1 min (29 cycles). To confirm endothelial integrity, eNOS primers (forward: 5=-CCTGCCCCCATGACTTTG-3= and reverse: 5=-TC-CCGGTAGAGATGGTCCAG-3=) were used (25) . The resulting PCR products were separated using agarose gel electrophoresis, and the bands were visualized. Male mice used in experiments were maintained on standard chow with free access to drinking water. At 12-16 wk of age, WT and ePPAR␦ Ϫ/Ϫ mice were anesthetized with an overdose of pentobarbital (200 -250 mg/kg body wt ip) followed by exsanguination via cardiac puncture for blood collection. In some experiments that required only WT animals, male C57BL/6 mice were obtained from the Jackson Laboratory. Aortas and common carotid arteries were carefully removed and dissected free from connective tissue in cold (4°C) modified Krebs-Ringer solution [containing (in mmol/l) 118.6 NaCl, 4.7 KCl, 2. Systolic blood pressure. Systolic blood pressure was recorded in quiescent mice by the tail-cuff method (Harvard Apparatus, Kent, UK) as previously described (13) .
Glucose and cholesterol profile. Blood samples obtained through right ventricular puncture were immediately transferred to a tube containing EDTA. After centrifugation at 2,000 rpm (4°C, 10 min), supernatants were stored at Ϫ80°C until assayed. Cholesterol and high-density lipoprotein levels were measured using a Hitachi 912 chemistry analyzer (Roche Diagnostics, Indianapolis, IN) as previously described (14) . Glucose levels were measured in whole blood with Accu Check (Roche Diagnostics, Indianapolis, IN).
Leptin levels. Circulating leptin levels were quantified in plasma using sandwich enzyme immunoassay techniques (R&D Systems, Minneapolis, MN).
Vascular reactivity experiments with carotid arteries. Four-millimeter-long segments of common carotid arteries were studied under pressurized conditions in small vessel chambers (Living Systems Instrumentation, Burlington, VT) as previously described (11) . Carotid arteries were equilibrated for 60 min, after which their resting lumen diameter and media thickness were recorded. Concentrationdependent relaxations to ACh (10 Ϫ9 -10 Ϫ5 mol/l) were obtained during submaximal contractions to the thromboxane analog 9,11-dideoxy-11␣,9␣-epoxymethano-PGF2␣ (U-46619). Concentrations of U-46619 (3 ϫ 10 Ϫ8 -10 Ϫ7 mol/l) were selected to obtain the same submaximal contractions in WT and ePPAR␦ Ϫ/Ϫ mice (59 Ϯ 5% and 54 Ϯ 5%, respectively, n ϭ 6, P Ͼ 0.05). After washout and equilibration, responses to the NO donor diethylammonium (
Ϫ5 mol/l) were obtained.
Vascular reactivity experiments with aortic rings. Isolated aortic rings were mounted horizontally between a fixed and a movable stainless steel hook and placed in organ chambers for recording isometric tension (PowerLab, AD Instruments, Colorado Springs, CO) as previously described (10) . Data were acquired using LabChart Pro software (AD Instruments). In some rings, endothelial cells were mechanically removed and studied in parallel. Aortic rings were preincubated without or with catalase (1,400 U/ml for 20 min), and endothelium-dependent relaxations to ACh (10 Ϫ9 -10 Ϫ5 mol/l) were obtained during submaximal contractions to phenylephrine. Concentrations of phenylephrine (3 ϫ 10 Ϫ8 -3 ϫ 10 Ϫ7 mol/l) were selected to achieve the same submaximal contractions in WT and ePPAR␦ Ϫ/Ϫ mouse aortas without or with catalase. After washout and equilibration, endothelium-independent relaxations to DEA-NONOate (10 Ϫ10 -10 Ϫ5 mol/l) were studied after preincubation without or with catalase (1,400 U/ml for 20 min).
Measurements of GTP-cyclohydrolase I enzyme activity and biopterin levels. Aortas were homogenized in buffer containing 50 mmol/l Tris (pH 7.4), 1 mmol/l DTT, and 1 mmol/l EDTA at 4°C and were centrifuged at 10,000 rpm. Enzymatic activities of GTP-cyclohydrolase I (GTPCH I) were obtained by the amount of neopterin formation (13) . Biopterin levels were determined after differential oxidation under acid [which converts both tetrahydrobiopterin (BH 4) and 7,8-dihydrobiopterin (BH2) to biopterin] and base (which converts only BH2 to biopterin) conditions by reverse-phase HPLC (Beckman Coulter) as previously described. BH4 content was calculated from the difference in biopterin levels after acid and base oxidations (12) .
Detection of superoxide anion. Intracellular superoxide anion production was quantified using a HPLC/fluorescence assay that uses dihydroethidium as a probe as previously described (13) .
Measurement of H 2O2. An Amplex red H2O2 assay kit (Life Technologies, Grand Island, NY) was used to perform measurements of H 2O2 content in the mouse aorta (13) . Briefly, aortas were homogenized in buffer solution provided by the kit and centrifuged at top speed. H2O2 measurements were performed in supernatants according the manufacturer's instructions and normalized against protein levels.
Measurement of cGMP levels. A cGMP colorimetric ELISA kit (Cell Biolabs, San Diego, CA) was used. In brief, aortas (10 -15 mm in length) were incubated for 60 min in minimal essential medium (containing 0.1% BSA, 100 U/ml penicillin, and 100 g/ml streptomycin, GIBCO) with 3-isobutyl-1-methylxanthine (IBMX; 100 mol/l) to inhibit the degradation of cyclic nucleotides by phosphodiesterases. Aortas were then removed and quickly frozen in liquid N 2 until assayed. Some of the aortas were incubated with catalase (1,400 U/ml) for 60 min before IBMX. Aortas were homogenized in lysis buffer provided by the kit and centrifuged at top speed. Supernatants were used for cGMP measurements according the manufacturer's instructions and normalized against protein levels.
In separate experiments, WT (C57BL/6) mouse aortas with or without endothelium were used to study the effect of H 2O2 on cGMP production. In brief, aortas were incubated for 60 min in IBMXcontaining minimal essential medium, and the soluble guanylyl cyclase inhibitor 1H- [1, 2, 4] Data are means Ϯ SE; n ϭ 6 -8. WT mice, wild-type mice; ePPAR␦
mice, endothelium-specific peroxisome proliferator-activated receptor-␦-deficient mice. P Ͼ 0.05.
10 mol/l; 30 min) was then added to some of the rings. Afterward, aortic rings were incubated for 30 min with 100 M H 2O2. This concentration was selected based on a previous study (46) . Western blot analysis. Whole aortas were homogenized in lysis buffer (14) . Equal amounts of protein (50 g) were separated by SDS-PAGE and transferred to nitrocellulose membranes (Amersham), after which the membranes were probed using primary antibodies against eNOS and Ser 1177 -phosphorylated eNOS (BD Biosciences); CuZnSOD, MnSOD, extracellular (ec)SOD (Enzo), catalase, and ␤-actin (Sigma); and glutathione peroxidase 1 (GPx-1; AbFrontier). Bands were visualized using a commercially available ECL kit (Amersham), and densitometry was carried out using NIH Image (ScionImage, Scion, Frederick, MD).
To evaluate the contribution of the endothelium, aortas without and with endothelium were studied in parallel. Aortas were dissected free from surrounding fat and were opened lengthwise. The endothelial surface was incubated with 0.1% collagenase in PBS for 1 min at room temperature. Endothelial cells were removed carefully and softly using a surgical blade, and the aorta was washed with Krebs buffer and homogenized as described above.
Calculations and statistical analysis. All results are expressed as means Ϯ SE; n is the number of animals from which tissues were harvested. Relaxations (expressed as a percentage of maximal relaxations induced by papaverine) were determined for each individual concentration-response curve by nonlinear regression analysis. Concentration-response curves of the different groups were compared by ANOVA for repeated measurements followed by Bonferroni's correction. WT and ePPAR␦ Ϫ/Ϫ mice without and with endothelium were compared by two-way ANOVA for multiple comparisons. For simple comparisons between two groups of WT and ePPAR␦ Ϫ/Ϫ mice, an unpaired Student's t-test was used where appropriate. P values of Ͻ0.05 were considered significant.
RESULTS
Characterization of ePPAR␦
Ϫ/Ϫ mice. All mouse offspring were viable and grew and developed normally. Body weight did not differ between WT littermates and ePPAR␦ Ϫ/Ϫ mice ( Table 1) . Measurements of systolic blood pressure indicated that ePPAR␦ Ϫ/Ϫ mice were normotensive (Table 1 ). In addition, plasma lipid profiles, leptin, and blood glucose levels were unaltered in ePPAR␦ Ϫ/Ϫ mice ( Table 1) . PCR analysis of isolated endothelial cells from WT and ePPAR␦ Ϫ/Ϫ mouse aortas provided evidence showing that the PPAR-␦ gene is present in endothelial cells, and some expression was found in vascular smooth muscle cells and adventitia (Fig. 1) . The use of primers of exon 4 of the PPAR-␦ gene showed that exon 4 was absent in isolated endothelial cells of ePPAR␦ Ϫ/Ϫ mice (Fig. 1) .
Structure and function of common carotid arteries in ePPAR␦
Ϫ/Ϫ mice. The lumen diameter of common carotid arteries did not differ between WT and ePPAR␦ Ϫ/Ϫ mice (344 Ϯ 8 and 335 Ϯ 6 m, respectively, n ϭ 6). In addition, media thickness was unaltered in ePPAR␦ Ϫ/Ϫ mice (41 Ϯ 4 m) compared with WT littermates (44 Ϯ 2 m, n ϭ 6). However, endothelium-dependent relaxations to ACh were significantly impaired in common carotid arteries of ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05 vs. WT littermates; Fig. 2A ). Moreover, endotheliumindependent relaxations to the NO donor DEA-NONOate were also significantly reduced in ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05 vs. WT mice; Fig. 2B ).
Endothelial function of aortas in ePPAR␦ Ϫ/Ϫ mice. Endothelium-dependent relaxations to ACh were also significantly impaired in ePPAR␦ Ϫ/Ϫ aortas (P Ͻ 0.05 vs. WT aortas; Fig. 3A) . Moreover, increased contractions were observed in ePPAR␦ Ϫ/Ϫ aortas at higher concentrations of ACh (10
Ϫ5 mol/l). Incubation with catalase significantly improved relaxations to ACh in ePPAR␦ Ϫ/Ϫ aortas (P Ͻ 0.05; Fig. 3C ), whereas it had no effect in WT aortas (Fig. 3B) Endothelium-independent relaxations to DEA-NONOate were impaired, and the sensitivity (pD 2 ) to DEA-NONOate was significantly shifted to the right in aortas of ePPAR␦ Ϫ/Ϫ mice with intact endothelium (P Ͻ 0.05; Fig. 4A and Table 2 ). With removal of endothelial cells, sensitivity was generally shifted to the left in all groups of mice (Table 2) . However, relaxations to the NO donor were significantly improved in ePPAR␦ Ϫ/Ϫ arteries without endothelium compared with aortas with endothelium (P Ͻ 0.05; Table 2 ), and the difference between WT and ePPAR␦ Ϫ/Ϫ mice was abolished (Fig. 4B) . Interestingly, catalase also significantly improved endothelium-independent relaxations in ePPAR␦ Ϫ/Ϫ aortas with intact endothelium, whereas it had no effect in aortas without endothelium (Table 2) .
Protein expression of eNOS in ePPAR␦ Ϫ/Ϫ mice. Western blot analysis showed that the protein expression of phosphorylated eNOS at Ser 1177 was significantly decreased in aortas of ePPAR␦ Ϫ/Ϫ mice, whereas the protein expression of eNOS was unchanged (P Ͻ 0.05 vs. WT mice; Fig. 5) . Conversely, the protein expression of inducible NO synthase in WT and ePPAR␦ Ϫ/Ϫ blood vessels was weak and did not differ between both groups (data not shown).
Biopterin metabolism in ePPAR␦ Ϫ/Ϫ mice. BH 4 levels were significantly increased in ePPAR␦ Ϫ/Ϫ aortas (P Ͻ 0.05 vs. WT aortas; Fig. 6A ), whereas levels of BH 2 , the oxidative product of BH 4 , were unchanged (Fig. 6B) . The resulting BH 4 -to-BH 2 ratio did not differ between WT and ePPAR␦ Ϫ/Ϫ mice (Fig. 6C) . To investigate the mechanism of increased BH 4 levels, we examined the enzymatic activity of GTPCH I. Interestingly, GTPCH I activity was significantly increased in ePPAR␦ Ϫ/Ϫ aortas (P Ͻ 0.05 vs. WT aortas; Fig. 6D ), whereas the protein expression of GTPCH I was unaltered (Fig. 6, E and F) .
Measurements of superoxide anion and H 2 O 2 in ePPAR␦
mice. Levels of the stable fluorescent product 2-hydroxyethidium, which is formed from the reaction between dihydroethidium and superoxide anion, were similar between WT and ePPAR␦ Ϫ/Ϫ aortas (Fig. 7A) . In contrast, levels of H 2 O 2 were DEA-NONOate (-log mol/L) 5 10 Relaxation (%) DEA-NONOate (-log mol/L) 5 10 Relaxation (%) significantly increased in aortas of ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05; Fig. 7B) .
cGMP levels in ePPAR␦ Ϫ/Ϫ mice. cGMP levels were significantly enhanced in aortas from ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05 vs. WT mice; Fig. 8A ). In vitro incubation of ePPAR␦ Ϫ/Ϫ aortas with catalase (1,400 U/ml) significantly decreased cGMP levels (P Ͻ 0.05 vs. control ePPAR␦ Ϫ/Ϫ aortas; Fig.  8B ). Furthermore, incubation of WT aortas with H 2 O 2 resulted a significant increase in cGMP levels, which was blocked by treatment with ODQ (P Ͻ 0.05 vs. WT aortas; Fig. 8C ). Removal of endothelial cells abolished the stimulatory effects of H 2 O 2 on cGMP levels (Fig. 8D) .
Protein expressions of antioxidants in ePPAR␦ Ϫ/Ϫ mice. Western blot analyses indicated that expressions of SOD isoforms CuZnSOD, MnSOD, and ecSOD were unaltered in aortas of ePPAR␦ Ϫ/Ϫ mice (Fig. 9) . Interestingly, protein expressions of the H 2 O 2 detoxifying enzymes catalase and GPx-1 were both significantly decreased in ePPAR␦ Ϫ/Ϫ mice (P Ͻ 0.05 vs. WT mice; Fig. 10 ). Removal of the endothelium abolished the differences between WT and ePPAR␦ Ϫ/Ϫ mice (Fig. 10) .
DISCUSSION
The present study was designed to determine how genetic inactivation of PPAR-␦ in the endothelium affects the vascular function of large conduit arteries. Here, we present several novel findings. First, in aortas and carotid arteries of endothelium-specific PPAR-␦-deficient mice, endothelium-dependent and -independent relaxations were significantly impaired. Second, phosphorylation of eNOS at Ser 1177 was also reduced in ePPAR␦ Ϫ/Ϫ mouse aortas. Third, deletion of the endotheliumspecific PPAR-␦ gene significantly increased the biosynthesis of BH 4 in aortic walls. Fourth, protein expressions of catalase and GPx-1 were downregulated, which resulted in significantly increased H 2 O 2 content in the aortas of ePPAR␦ Ϫ/Ϫ mice. Finally, increased levels of cGMP were detected in aortas of ePPAR␦ Ϫ/Ϫ mice, and this increase in cGMP was inhibited in aortas treated with catalase.
Emerging evidence supports the notion that activation of PPAR-␦ exerts beneficial effects on vascular endothelial function (49) . Indeed, treatment with PPAR-␦ ligands improved endothelium-dependent relaxations in peripheral and cerebral arteries by increasing antioxidant capacity and a subsequent increase in the bioavailability of NO (14, 41, 47) . These observations are important because normal NO signaling is vasoprotective. In the present study, deletion of PPAR-␦ in the endothelium caused an impairment of endothelium-dependent relaxations to ACh in aortas and carotid arteries. This impaired relaxation may be caused by a decreased enzymatic activity of eNOS because in ePPAR␦ Ϫ/Ϫ mouse aortas, we also detected a downregulation of protein expression of phosphorylated eNOS at Ser 1177 . Phosphorylation of eNOS at serine has been reported to increase the enzymatic activity of eNOS and NO production, thereby accounting, in part, for the protection of vascular function (3). The most likely molecular mechanism for decreased eNOS phosphorylation at Ser 1177 may be explained by the high levels of H 2 O 2 detected in the aorta, as in previous studies reporting that long-term exposure of H 2 O 2 can attenuate eNOS phosphorylation (22) , increase the expression of arginase I (45), and impair endothelium-dependent relaxations (46) . Likewise, reductions in NO-mediated signaling have been reported in GPx-1-deficient mice aortas under basal conditions (15) . This is consistent with our observation that catalase was able to improve endothelium-dependent relaxations to ACh in aortas of ePPAR␦ Ϫ/Ϫ mice. We also wish to point out that this impairment of endothelial function in ePPAR␦ Ϫ/Ϫ mice was not caused by the increase in blood pressure or by an elevation of cholesterol or glucose levels.
We did not investigate the involvement of the cyclooxygenase pathway, and, therefore, we cannot rule out whether impaired endothelium-dependent relaxations in ePPAR␦ Ϫ/Ϫ mice were caused by increased generation of prostaglandins. We (10) have previously shown that endothelium-dependent relaxations to ACh in WT mouse aortas are entirely dependent on NO. Furthermore, treatment with catalase completely prevented increased contractions to higher concentrations of ACh (10 Ϫ6 -10 Ϫ5 mol/l), thus suggesting that the impairment of endothelium-dependent relaxations in ePPAR␦ Ϫ/Ϫ mice is mediated by H 2 O 2 . In this regard, it has been previously reported that H 2 O 2 is involved in the increased synthesis of prostaglandins causing endothelial dysfunction (16) . Whether cyclooxygenase is activated in ePPAR␦ Ϫ/Ϫ mice remains to be determined.
Alteration of the responsiveness of vascular smooth muscle cells to NO may also explain to the impairment of endothelium-dependent relaxations. Indeed, we observed that endothelium-independent relaxations to the NO donor DEA-NONOate were reduced in aortas and carotid arteries of ePPAR␦ Ϫ/Ϫ mice, thereby indicating that reduced reactivity of NO in vascular smooth muscle cells may be responsible for the impaired endothelium-dependent relaxations to ACh. Moreover, previous studies (33, 52) have shown that an elevation of cGMP reduced the vasodilator effect to NO. It is important to note that exogenous catalase administration improved endothelium-independent relaxations of aortas in ePPAR␦ Ϫ/Ϫ mice. Likewise, removal of the endothelium also abolished the difference in DEA-NONOate responses between WT and ePPAR␦ Ϫ/Ϫ mouse aortas, suggesting that increased H 2 O 2 levels in the endothelium are responsible for the impairment of relaxations to DEA-NONOate. Furthermore, catalase did not affect endothelium-independent relaxations to the NO donor in ePPAR␦ Ϫ/Ϫ mouse aortas without endothelium, ruling out the possibility that H 2 O 2 production is increased in vascular smooth muscle cells. This is in line with our observations that protein expressions of catalase and GPx-1 were not different between WT and ePPAR␦ Ϫ/Ϫ mouse aortas without endothelium.
The impaired endothelial function in ePPAR␦ Ϫ/Ϫ mice may be due to suboptimal production of BH 4 because BH 4 is an essential cofactor for optimal enzymatic activity of eNOS in endothelial cells (24) . In the present study, however, we found that endothelium-specific deletion of the PPAR-␦ gene signif- icantly increased BH 4 levels in aortas, whereas levels of BH 2 remained unchanged. Furthermore, the enzymatic activity of GTPCH I was enhanced in ePPAR␦ Ϫ/Ϫ mouse aortas, indicating that the increase in BH 4 levels was caused by increased de novo biosynthesis of BH 4 via GTPCH I. The elevation of BH 4 again indicates that the impaired endothelial function was not due to BH 4 deficiency, which would cause eNOS uncoupling and generation of superoxide anion (24) .
Several potential mechanisms may explain the observed increase in BH 4 production. It is well established that proinflammatory cytokines upregulate the expression and activity of GTPCH I, thereby increasing levels of BH 4 (39) . Based on established anti-inflammatory effects of PPAR-␦ activation, it is conceivable that genetic inactivation of PPAR-␦ in the endothelium may mimic a proinflammatory environment (5). However, this explanation is unlikely because a proinflammatory environment would decrease expression of eNOS (56) . In the present study, eNOS protein expression was not affected by deletion of the PPAR-␦ gene in the vascular endothelium. It is possible that the levels of BH 4 are dependent on levels of H 2 O 2 because H 2 O 2 is also known as a stimulator of GTPCH I enzymatic activity and production of BH 4 (43) .
The elevated H 2 O 2 levels in ePPAR␦ Ϫ/Ϫ mice may be caused by decreased expression and function of H 2 O 2 detoxifying enzymes. Indeed, loss of PPAR-␦ in the endothelium downregulated protein expressions of both catalase and GPx-1, and this, in turn, elevated production of H 2 O 2 in mouse aortas. More importantly, removal of endothelial cells abolished the differences between WT and ePPAR␦ Ϫ/Ϫ mice, suggesting that the decreased catalase and GPx-1 protein expressions are endothelium specific. Both catalase and GPx-1 are antioxidant enzymes that catalyze the dismutation of H 2 O 2 to oxygen and water and thus protect cells against this potentially toxic molecule (1) . In addition, a functional PPAR response element is located in the promoter region of the catalase gene, indicating that catalase expression is directly regulated by PPAR (20) . In this regard, recent evidence indicates that treatment of mice with the PPAR-␦ ligand GW-501516 increased protein expression of catalase, thereby protecting vascular function by reducing the concentration of H 2 O 2 (41) . Moreover, overexpression of catalase can inhibit NF-B activation and protect cells and tissues from inflammation and the development of atherosclerosis (32, 53) .
A significant increase of cGMP levels was also detected in aortas of ePPAR␦ Ϫ/Ϫ mice compared with WT mice. H 2 O 2 is the most likely candidate responsible for activation of the cGMP pathway because similar observations have been reported in several studies (7, 18, 26, 42) . Moreover, incubation of ePPAR␦ Ϫ/Ϫ mouse aortas with catalase significantly reduced levels of cGMP, thereby indicating that H 2 O 2 causes increased production of cGMP in ePPAR␦ Ϫ/Ϫ aortas. Consistent with this observation, catalase normalized relaxations to ACh and relaxations to DEA-NONOate. Notably, exogenous H 2 O 2 increased cGMP levels only in aortas with intact endothelium. This observation suggests that the H 2 O 2 -induced elevation of cGMP levels in ePPAR␦ Ϫ/Ϫ aortas might be dependent on chronically increased formation of NO in endothelial cells (46) . A previous study (21) It has been previously reported that genetic inactivation of PPAR-␦ reduces adipogenesis in mice (4) and that PPAR-␦-deficient mice are more prone to weight gain on a high-fat diet (51) . In contrast, activation of PPAR-␦ is protective against obesity and lipid accumulation (44, 51) . Moreover, prior studies (8, 48) have reported a potential inhibitory function of PPAR-␦ expression and function of leptin. Conversely, circulating leptin levels were increased in neuron-specific PPAR-␦-deficient mice, indicating that leptin was regulated by PPAR-␦ (28, 48) . However, in our study, we did not observe any changes in body weight and circulating levels of leptin in ePPAR␦ Ϫ/Ϫ mice, suggesting that the vascular alterations observed in these mice are independent of leptin.
A previous study by Kleinhenz and colleagues (27) reported that endothelium-specific deletion of the PPAR-␥ gene increased ROS (although the exact nature of the ROS was not identified), impaired endothelium-dependent relaxations to ACh in aortas, and increased arterial blood pressure. Moreover, levels of endothelial NO were significantly reduced (27) . In the present study, however, we found that in ePPAR␦ Ϫ/Ϫ mice, endothelial dysfunction is caused by selective reduction of the antioxidant capacity responsible for the inactivation of H 2 O 2 and subsequent increase in H 2 O 2 levels. Thus, it is becoming apparent that in the endothelium, each PPAR subserves an isoform-specific set of functions (6) . Of note, there are no reported studies regarding endothelium-specific PPAR-␣-deficient mice.
In conclusion, we demonstrate that endothelium-specific deletion of the PPAR-␦ gene causes an impairment of the vascular responsiveness to NO. Increased cGMP levels caused by elevation of H 2 O 2 appear to be an important mechanism underlying the impairment of vasodilator function. Thus, functional endothelial PPAR-␦ maintains normal expression of catalase and GPx-1, thereby protecting the vascular wall from the effects of excessive production of H 2 O 2 . In addition, we speculate that the loss of PPAR-␦ in endothelial cells, and the consequent increase in the local concentration of H 2 O 2 , predisposes the blood vessel wall to oxidative stress.
